1. Home
  2. LFMD vs SIGA Comparison

LFMD vs SIGA Comparison

Compare LFMD & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LifeMD Inc.

LFMD

LifeMD Inc.

HOLD

Current Price

$3.82

Market Cap

218.1M

Sector

Health Care

ML Signal

HOLD

Logo SIGA Technologies Inc.

SIGA

SIGA Technologies Inc.

HOLD

Current Price

$3.16

Market Cap

230.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LFMD
SIGA
Founded
1994
1995
Country
United States
United States
Employees
384
N/A
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
218.1M
230.2M
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
LFMD
SIGA
Price
$3.82
$3.16
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$9.14
N/A
AVG Volume (30 Days)
679.7K
768.8K
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
13.24%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$17.52
N/A
Revenue Next Year
$18.73
$224.81
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.60
$3.01
52 Week High
$7.32
$9.62

Technical Indicators

Market Signals
Indicator
LFMD
SIGA
Relative Strength Index (RSI) 43.13 33.81
Support Level $3.39 $3.01
Resistance Level $4.19 $4.84
Average True Range (ATR) 0.25 0.17
MACD -0.01 0.01
Stochastic Oscillator 42.63 16.67

Price Performance

Historical Comparison
LFMD
SIGA

About LFMD LifeMD Inc.

LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.

About SIGA SIGA Technologies Inc.

SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.

Share on Social Networks: